Pharmacological profile of once-weekly injectable semaglutide for chronic weight management-Reference-Cited by-同舟云学术

Pharmacological profile of once-weekly injectable semaglutide for chronic weight management

Published:2022-03-04 Issue:3 Volume:15 Page:251-268
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Lau David C. W.¹,Batterham Rachel L²³⁴,le Roux Carel W.⁵^ORCID

Affiliation:

1. Biochemistry and Molecular Biology, Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

2. Centre for Obesity Research, Department of Medicine, University College London, London, UK

3. Bariatric Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK

4. National Institute for Health Research, Biomedical Research Centre, University College London Hospital, London, UK

5. School of Medicine, University College Dublin, Dublin, Ireland

Funder

Novo Nordisk A/S

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2070473

Reference83 articles.

1. The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications

2. Obesity in adults: a clinical practice guideline

3. World Health Organization. Obesity and Overweight 2021. Last accessed 2022 Mar 24. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

4. Obes Res. National Institutes of Health. 1998.

5. The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bettie’s travels: How pigs enable new connections between human health innovations and industrial agricultural pork production in Denmark;Social Studies of Science;2024-08-16

2. EXPLORING THE UNINTENDED CONSEQUENCES OF MISUSE OF WEGOVY AND OZEMPIC IN WEIGHT MANAGEMENT: A COMPREHENSIVE REVIEW;International Journal of Pharmacy and Pharmaceutical Sciences;2024-06-01

3. A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity;Nature Communications;2023-12-14

4. The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research;Expert Review of Anticancer Therapy;2023-03-28

5. A systematic review of the safety of tirzepatide-a new dual GLP1 and GIP agonist - is its safety profile acceptable?;Frontiers in Endocrinology;2023-03-27